[go: up one dir, main page]

AR013960A1 - NEW COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY - Google Patents

NEW COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY

Info

Publication number
AR013960A1
AR013960A1 ARP980104638A ARP980104638A AR013960A1 AR 013960 A1 AR013960 A1 AR 013960A1 AR P980104638 A ARP980104638 A AR P980104638A AR P980104638 A ARP980104638 A AR P980104638A AR 013960 A1 AR013960 A1 AR 013960A1
Authority
AR
Argentina
Prior art keywords
methods
neuraminidase
group
new compounds
therapy
Prior art date
Application number
ARP980104638A
Other languages
Spanish (es)
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR013960A1 publication Critical patent/AR013960A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describen nuevos compuestos. Los compuestos comprenden en general un grupo acídico, un grupo básico, un grupo amino substituido o N-acilo yun grupo que tiene una porcion alcano opcionalmente hidroxilada. Las composiciones farmacéuticas que comprenden los inhibidores de la invenciontambién han sido descriptas. También se describen métodos para inhibir neuraminidasa en muestras que se sospecha que contienen neuraminidasa. Sedescriben también materiales antigénicos, polímeros, conjugados de los compuestos de la invencion con rotulos y métodos de ensayo para detectar laactividad de neuraminidasa.New compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino group or N-acyl and a group having an optionally hydroxylated alkane portion. Pharmaceutical compositions comprising the inhibitors of the invention have also been described. Methods for inhibiting neuraminidase are also described in samples suspected to contain neuraminidase. Antigenic materials, polymers, conjugates of the compounds of the invention are also described with labels and test methods for detecting the activity of neuraminidase.

ARP980104638A 1997-09-17 1998-09-17 NEW COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY AR013960A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5930897P 1997-09-17 1997-09-17
US6019597P 1997-09-26 1997-09-26
US93864497A 1997-09-26 1997-09-26

Publications (1)

Publication Number Publication Date
AR013960A1 true AR013960A1 (en) 2001-01-31

Family

ID=27369627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104638A AR013960A1 (en) 1997-09-17 1998-09-17 NEW COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY

Country Status (15)

Country Link
EP (1) EP1015417A1 (en)
JP (1) JP2001516739A (en)
KR (1) KR20010024123A (en)
CN (1) CN1272105A (en)
AR (1) AR013960A1 (en)
AU (1) AU747702B2 (en)
BR (1) BR9812649A (en)
CA (1) CA2303323A1 (en)
EA (1) EA003989B1 (en)
ID (1) ID25516A (en)
IL (1) IL134691A0 (en)
IN (1) IN190983B (en)
NZ (1) NZ502988A (en)
TR (1) TR200000723T2 (en)
WO (1) WO1999014185A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9813480A (en) * 1997-12-17 2000-10-10 Biocryst Pharm Inc Substituted cyclopentane neuraminidase inhibitor compounds, composition and methods of inhibiting influenza virus neuraminidase and treatment of influenza virus infection
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
EP1059283B1 (en) * 1999-06-11 2003-05-28 F. Hoffmann-La Roche Ag Process for preparing neuraminidase inhibitor ro-64-0796
AU7608100A (en) * 1999-10-19 2001-04-30 Abbott Laboratories 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
JP2001131144A (en) * 1999-11-02 2001-05-15 Sagami Chem Res Center Method for producing 7-azabicyclo [4.1.0] hept-3-en-3-carboxylic acid esters
US6403824B2 (en) * 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
WO2001080892A1 (en) * 2000-04-25 2001-11-01 Sankyo Company, Limited Preventives for influenza
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
JP2009522227A (en) * 2005-12-28 2009-06-11 エフ．ホフマン−ラ ロシュ アーゲー Epoxide intermediates in the synthesis of Tamiflu
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
CN102597120B (en) * 2009-11-11 2015-05-27 3M创新有限公司 Polymeric compositions and method of making and articles thereof
DE102011117128A1 (en) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Compounds for the treatment of influenza
RU2469020C1 (en) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene-carboxylic acids, their esters and method for using
CN102659615B (en) * 2012-05-09 2014-05-07 中国药科大学 Derivatives of oseltamivir, and preparation method and medical application thereof
RU2520836C1 (en) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-amino-5-(2,2-difluoroacetylamino)-3-(1-ethylpropoxy)-cyclohex-1-enecarboxylic acid and its ethers, method of obtaining and applying thereof
RU2633085C2 (en) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Antiviral drug as capsules and method for its preparation
CN105439884A (en) * 2015-10-27 2016-03-30 沈阳药科大学 Oseltamivir preparation method
CN108047076B (en) * 2017-12-26 2020-05-08 杭州新博思生物医药有限公司 Preparation method of oseltamivir enantiomer
CN110194728B (en) * 2019-06-19 2021-04-30 湖南华腾制药有限公司 Continuous synthesis method of oseltamivir phosphate intermediate
CN114057599A (en) * 2020-07-29 2022-02-18 广州市恒诺康医药科技有限公司 Neuraminidase inhibitor compound, pharmaceutical composition and application thereof
CN116375595A (en) * 2023-03-31 2023-07-04 重庆医药高等专科学校 A kind of preparation method and refining method of oseltamivir phosphate
CN116666669B (en) * 2023-07-25 2023-10-03 四川大学 VN-supported Ir clusters, their preparation methods and their use in catalysts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282950B6 (en) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Alpha-D-neuraminic acid derivatives, processes for their preparation, their use, and pharmaceutical compositions based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
AU720933B2 (en) * 1995-02-27 2000-06-15 Gilead Sciences, Inc. Novel selective inhibitors of viral or bacterial neuraminidases
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
NZ507106A (en) * 1996-08-23 2003-01-31 Gilead Sciences Inc Preparation of cyclohexene carboxylate derivatives

Also Published As

Publication number Publication date
IN190983B (en) 2003-09-06
BR9812649A (en) 2000-08-22
JP2001516739A (en) 2001-10-02
AU747702B2 (en) 2002-05-16
EA200000332A1 (en) 2000-10-30
ID25516A (en) 2000-10-05
AU9569498A (en) 1999-04-05
WO1999014185A1 (en) 1999-03-25
CN1272105A (en) 2000-11-01
EP1015417A1 (en) 2000-07-05
EA003989B1 (en) 2003-12-25
KR20010024123A (en) 2001-03-26
NZ502988A (en) 2002-08-28
TR200000723T2 (en) 2001-06-21
IL134691A0 (en) 2001-04-30
CA2303323A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
AR013960A1 (en) NEW COMPOUNDS AND METHODS FOR SYNTHESIS AND THERAPY
ES2118674T3 (en) NEW SELECTIVE INHIBITORS FOR VIRAL NEURAMINIDASES OR BACTERICIDES.
CY2018023I1 (en) SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENIUM COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS
CY1106992T1 (en) WALNUT F AND RELATED COMPOUNDS
PT1105122E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITORS
ES2184408T3 (en) TRANSDERMAL SYSTEM CONTAINING AN ANTIOXIDANT.
UY26092A1 (en) USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES
NO20005224L (en) BTK inhibitors and methods for their identification and use
EA200000868A1 (en) PHOSPHOLIPAZ INHIBITORS
ES2136415T3 (en) PROCEDURE FOR THE MANUFACTURE OF POLYESTERS USING CATALYST COMBINATIONS CONTAINING TITANIUM AND INHIBITOR.
NO984004D0 (en) Method of detecting influenza viruses and compounds for use in the method
PT884994E (en) USES OF ADHESIVE FOR DENTAL PROTESIS CONTAINING ALOE EXTRACT
IT1291623B1 (en) PROCEDURE FOR CONJUGATION OF CHELANTS WITH MOLECULES CONTAINING AMINE GROUPS
MX9207137A (en) NEW OLIGODESOXYRIBONUCLEOTIDES, WHICH HAVE AN ANTI-ISCHEMIC ACTIVITY, AND METHODS FOR THEIR PREPARATION
ES2189072T3 (en) NEW BENZO-HETEROCICLIC CYCLALKINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2179529T3 (en) BIAROMATIC COMPOUNDS UNITED BY A HETEROETYLLENE RADICAL, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM.
ES2285735T3 (en) MOLECULAR MODEL FOR VLA-4 INHIBITORS.
HN1999000101A (en) FKBP INHIBITORS.
CA2188835A1 (en) Novel compounds and methods for synthesis and therapy
HN1999000043A (en) PROCEDURE FOR RENTING STERICALLY IMPAIRED SULFONAMIDES.
DK0952982T3 (en) New Hepatitis B Inhibitors
UA1766S (en) SET OF LABELS FOR BOTTLE
UA1769S (en) SET OF LABELS FOR BOTTLE
UA2733S (en) SET OF LABELS FOR BOTTLE
ECSP003420A (en) USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES

Legal Events

Date Code Title Description
FB Suspension of granting procedure